ProCE Banner Activity

How I Manage My Patients With MCL, CLL, and SLL

Clinical Thought

Expert nurse practitioner Beth Faiman discusses evidence-based recommendations for how best to incorporate new therapeutic options for patients with chronic lymphocytic leukemia and mantle cell lymphoma.

Released: June 16, 2022

Expiration: June 15, 2023

No longer available for credit.

Share

Faculty

Beth Faiman

Beth Faiman, PhD, MSN, APN-BC, AOCN, BMTCN, FAAN, FAPO

Cleveland Clinic Taussig Cancer Institute
Department of Hematology and Medical Oncology
Member, Population and Cancer Prevention Program
Case Comprehensive Cancer Center
Cleveland, Ohio

Acknowledgement

This activity is supported an educational grant from AstraZeneca.

Supporters

AstraZeneca

Target Audience

NPs and PAs in oncology

Disclosure

Beth Faiman PhD, MSN, APRN-BC, AOCN has no relevant financial relationships to disclose.

Disclaimer

The opinions or views expressed in this CE/CME activity do not necessarily reflect the opinions or recommendations of Practicing Clinicians Exchange or any educational supporter.

Additional Information

Program Medium

This program has been made available online.